| Name | N-[1-[(2R,3R,5S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide |
|---|---|
| Synonyms |
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-3'-deoxycytidine
N4-benzoyl-5'-O-dimethoxytrityl-3'-deoxycytidine N4-Benzoyl-3A'A inverted exclamation markA'A-deoxy-5A'A inverted exclamation markA'A-O-DMT-D-cytidine N4-benzoyl-5'-O-dimethoxytrityl-3'-deoxyribicytidine Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-3'-deoxy- N4-Benzoyl-3'-deoxy-5'-O-DMT-cytidine |
| Description | N4-Benzoyl-5’-O-(4,4-dimethoxytrityl)-3’-deoxy cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Molecular Formula | C37H35N3O7 |
| Molecular Weight | 633.69 |
| Exact Mass | 633.247498 |
| PSA | 121.14000 |
| LogP | 6.22 |
| Index of Refraction | 1.626 |
| Precursor 8 | |
|---|---|
| DownStream 1 | |